Clin2
NCT05454566Possibly a fitNot yet recruiting

Study testing a new medicine for knee osteoarthritis pain

Osteoarthritis, Knee

Part of Bones, joints & muscles clinical trials.

This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
18 people
Ages
50 years to 80 years
Study type
Interventional

Who can take part

  • Your BMI is between 18 and 40
  • Your “worst” knee osteoarthritis is mild to moderate (Kellgren-Lawrence grade 2 or 3)
  • Your knee pain is rated 4 to 9 out of 10 right now
  • Your knee function for daily activities is above 25 on a 0–100 scale
  • You have taken stable pain relief for at least 4 weeks (including NSAIDs, if you use them)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07509307Recruiting· Phase 3
Study of a new medicine for weight loss and knee pain in osteoarthritis

This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.

Escondido, California
NCT05752032Enrolling by invitation
Long-term follow-up after ICM-203 or placebo treatment

This study checks on people who previously received ICM-203 or a matching placebo. It helps researchers understand the longer-term safety and effects of the treatment over time.

Adelaide, South Australia
NCT07052851Not yet recruiting
Testing a new knee injection for mild to moderate osteoarthritis

This trial tests a new type of knee injection called CCoat for people with mild to moderate knee osteoarthritis. The goal is to see if it helps reduce pain, stiffness, and joint symptoms.

NCT07641517Recruiting· Phase 2
Testing LY4065967 for chronic knee osteoarthritis pain

This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.

Birmingham, Alabama
NCT06343714Recruiting· Phase 1
Testing a new drug for knee osteoarthritis pain

This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.

Brisbane, Queensland
NCT07481630Recruiting· Phase 3
Testing a new medicine for weight loss and knee pain

This study tests if a new medicine called NNC0487-0111 can help people with extra weight and knee osteoarthritis lose weight and reduce knee pain. If you have knee pain most days and are willing to stop pain relievers for short periods, you may be able to join.

Phoenix, Arizona

Hear when a new Osteoarthritis, Knee trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.